Patient-derived organoids as a platform for drug screening in metastatic colorectal cancer

Introduction: Most advanced colorectal cancers are aggressive, and there is a lack of effective methods for selecting appropriate anticancer regimens. Patient-derived organoids (PDOs) have emerged as preclinical platforms for modeling clinical responses to cancer therapy. Methods: In this study, we...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Xingfeng, Jiang, Yan, Zhang, Long, Li, Yaqi, Hu, Xiang, Hua, Guoqiang, Cai, Sanjun, Mo, Shaobo, Peng, Junjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239948/
https://www.ncbi.nlm.nih.gov/pubmed/37284236
http://dx.doi.org/10.3389/fbioe.2023.1190637

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239948/
https://www.ncbi.nlm.nih.gov/pubmed/37284236
http://dx.doi.org/10.3389/fbioe.2023.1190637

Ejemplares similares